Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 17.3 (17.2, 17.4) N/A 67,373 falling falling trend -0.7 (-1.3, -0.1)
Puerto Rico 6 9.0 (8.5, 9.4) N/A 367 stable stable trend -0.7 (-10.4, 10.1)
District of Columbia 6 12.5 (11.3, 13.8) 50 (48, 50) 85 stable stable trend -2.7 (-13.7, 0.0)
Hawaii 7 13.5 (12.8, 14.3) 49 (47, 50) 252 stable stable trend -0.1 (-1.9, 1.0)
Nevada 6 14.0 (13.4, 14.6) 48 (46, 50) 510 stable stable trend 0.7 (-0.3, 1.7)
Colorado 6 14.8 (14.4, 15.2) 47 (41, 48) 944 rising rising trend 0.8 (0.4, 1.3)
California 7 14.9 (14.8, 15.1) 46 (42, 47) 6,644 stable stable trend 0.4 (-0.1, 0.9)
Massachusetts 7 15.0 (14.6, 15.4) 45 (40, 48) 1,307 falling falling trend -4.4 (-8.1, -0.8)
Vermont 6 15.3 (14.1, 16.6) 44 (27, 49) 136 stable stable trend 0.0 (-1.2, 1.2)
Maryland 6 15.4 (15.0, 15.8) 43 (35, 47) 1,146 stable stable trend 0.2 (-3.6, 0.9)
Washington 5 15.5 (15.1, 15.9) 42 (35, 46) 1,388 stable stable trend -0.2 (-1.0, 0.3)
Oregon 6 15.5 (15.1, 16.0) 41 (34, 47) 832 falling falling trend -3.0 (-4.9, -0.9)
Utah 7 15.6 (14.9, 16.2) 40 (30, 47) 454 rising rising trend 2.7 (2.3, 3.3)
Connecticut 7 15.7 (15.2, 16.3) 39 (31, 45) 721 stable stable trend 0.3 (-0.7, 0.9)
New Jersey 7 15.7 (15.4, 16.1) 38 (33, 44) 1,804 stable stable trend 0.2 (-0.6, 0.6)
Florida 6 15.7 (15.5, 16.0) 37 (34, 43) 4,689 rising rising trend 0.6 (0.4, 0.9)
Wyoming 6 15.8 (14.5, 17.3) 36 (23, 48) 112 stable stable trend 1.4 (-0.1, 3.1)
Virginia 6 15.9 (15.5, 16.2) 35 (32, 43) 1,638 stable stable trend 0.7 (-1.6, 1.3)
Michigan 6 16.4 (16.1, 16.7) 34 (27, 37) 2,084 stable stable trend -0.4 (-0.9, 0.0)
New York 7 16.4 (16.2, 16.6) 33 (27, 36) 4,080 stable stable trend 0.3 (-0.1, 0.6)
Arizona 6 16.5 (16.1, 16.9) 32 (26, 37) 1,443 stable stable trend -2.9 (-5.3, 0.3)
Pennsylvania 6 16.6 (16.3, 16.8) 31 (26, 35) 2,806 falling falling trend -3.7 (-5.9, -1.7)
Rhode Island 6 16.6 (15.6, 17.6) 30 (20, 44) 231 stable stable trend 0.1 (-0.6, 0.9)
New Mexico 7 16.6 (15.9, 17.4) 29 (24, 41) 422 rising rising trend 1.8 (1.6, 2.1)
New Hampshire 6 17.1 (16.2, 18.0) 28 (17, 38) 318 rising rising trend 1.1 (0.4, 1.8)
Delaware 6 17.1 (16.1, 18.2) 27 (16, 41) 225 rising rising trend 0.7 (0.2, 1.3)
Maine 6 17.3 (16.4, 18.2) 26 (16, 36) 343 rising rising trend 1.0 (0.3, 1.7)
Montana 6 17.4 (16.4, 18.4) 25 (14, 37) 246 rising rising trend 2.1 (1.4, 3.0)
South Carolina 6 17.5 (17.0, 18.0) 24 (19, 29) 1,138 stable stable trend -2.7 (-7.5, 1.5)
Georgia 7 17.9 (17.5, 18.2) 23 (17, 27) 2,146 rising rising trend 1.9 (1.5, 2.4)
Ohio 6 18.0 (17.7, 18.4) 22 (17, 26) 2,648 stable stable trend 1.1 (-0.3, 1.4)
Minnesota 6 18.1 (17.6, 18.6) 21 (15, 26) 1,239 rising rising trend 1.5 (1.0, 2.1)
Illinois 7 18.1 (17.8, 18.4) 20 (16, 25) 2,778 rising rising trend 0.5 (0.1, 0.8)
South Dakota 6 18.5 (17.3, 19.8) 19 (9, 29) 195 rising rising trend 2.0 (1.2, 2.8)
Alabama 6 18.5 (18.0, 19.0) 18 (12, 24) 1,149 rising rising trend 1.9 (1.5, 2.3)
Idaho 7 18.7 (17.8, 19.5) 17 (10, 26) 390 rising rising trend 2.1 (1.6, 2.6)
Nebraska 6 18.7 (17.9, 19.5) 16 (10, 26) 422 rising rising trend 1.6 (0.8, 2.4)
North Carolina 6 18.8 (18.4, 19.1) 15 (12, 20) 2,387 rising rising trend 0.9 (0.5, 1.2)
Wisconsin 6 19.2 (18.7, 19.6) 14 (10, 18) 1,429 stable stable trend 1.3 (-2.5, 2.4)
Alaska 6 19.3 (17.8, 20.8) 13 (3, 27) 146 rising rising trend 1.3 (0.5, 2.3)
North Dakota 6 19.5 (18.2, 20.9) 12 (3, 25) 173 rising rising trend 2.1 (1.4, 2.9)
Missouri 6 19.8 (19.4, 20.3) 11 (7, 14) 1,504 rising rising trend 1.4 (0.9, 1.9)
Kansas 6 19.9 (19.2, 20.6) 10 (6, 16) 676 rising rising trend 1.8 (1.2, 2.3)
Tennessee 6 20.0 (19.6, 20.5) 9 (7, 13) 1,680 stable stable trend -2.5 (-5.2, 0.6)
Iowa 7 20.5 (19.9, 21.2) 8 (4, 13) 810 rising rising trend 1.5 (0.7, 2.9)
Texas 7 20.6 (20.3, 20.8) 7 (5, 10) 6,101 stable stable trend -0.4 (-1.3, 0.3)
Arkansas 6 21.2 (20.5, 21.9) 6 (2, 9) 773 stable stable trend -0.7 (-2.7, 1.0)
Oklahoma 6 21.3 (20.7, 21.9) 5 (2, 8) 975 rising rising trend 2.3 (1.9, 2.7)
Kentucky 7 21.4 (20.9, 22.0) 4 (2, 8) 1,179 stable stable trend 0.9 (-0.4, 1.6)
West Virginia 6 21.5 (20.7, 22.4) 3 (2, 9) 522 rising rising trend 2.3 (1.8, 2.9)
Mississippi 6 21.9 (21.2, 22.7) 2 (2, 6) 781 stable stable trend -2.6 (-6.7, 1.5)
Louisiana 7 23.4 (22.8, 23.9) 1 (1, 2) 1,285 stable stable trend 1.1 (0.0, 1.7)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 10/11/2024 12:01 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. The Average Annual Percent Change (AAPC) is based on the APCs calculated by Joinpoint. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected counties.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
7 Source: SEER November 2023 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2023 data.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top